The FDA warns consumers to stop using EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to possible bacterial contamination. Using the contamination tears increases the risk of eye infection, which could lead to permanent blindness or death.
As of January 2023, 55 patients who have used artificial tears have developed an infection. Those affected have been hospitalized, suffered permanent vision loss from the infection, and one person has died.
Global Pharma Healthcare is voluntarily recalling the products at issue. The products being recalled are Ezricare NDC 79503-0101-15, UPC 3 79503 101157; and Delsam Pharma’s NDC 72570-121-15, UPC -72570-0121-15
The attorneys at Finkelstein, Blankinship, Frei-Pearson & Garber, LLP have successfully represented consumers in similar matters. If you have purchased or know someone who has purchased EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears and were harmed by the product, contact us to discuss your legal options.